menu Search
SKIIP

SKIIP

nicotine

Manufacturer:

Wellesta

Distributor:

Buergli Pharma
Concise Prescribing Info Full Prescribing Info Contents Description Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing
Concise Prescribing Info
Contents
Nicotine
Indications/Uses
Management of nicotine dependence.
Click to view SKIIP detailed prescribing information
Dosage/Direction for Use
Begin on quit day using 1 loz every 1-2 hr. Use 1 loz when urge to smoke occurs, do not use >1 at a time. Do not use >1 loz per hr, >5 loz in 6 hr & >20 loz per day. Recommended duration of use: 12-wk treatment course.
Click to view SKIIP detailed prescribing information
Overdosage
View SKIIP overdosage for action to be taken in the event of an overdose.
Administration
Should be taken on an empty stomach: Do not chew or swallow. Do not eat or drink while loz is in the mouth. Avoid drinking acidic beverages (eg, coffee or soda) for 15 min prior to sucking the loz.
Contraindications
Hypersensitivity. Not to be taken by non-smokers.
Click to view SKIIP detailed prescribing information
Special Precautions
Patients w/ recent heart attack, stroke, severe heart rhythm problems or chest pain; any heart problems; kidney or liver disease; stomach/duodenal ulcers or an inflamed oesophagus/gullet; seizures; overactive thyroid gland; high BP, angina or circulatory problems; pheochromocytoma; mouth inflammation or sore throat. Not recommended for patients who have found other forms of nicotine replacement therapy unsatisfactory. Reduce or discontinue use in case of an increase in heart problems. Monitor blood sugar levels more often than usual if patient has diabetes; insulin or medication requirements may change. Effect of some medicines can be altered when patient stops smoking. Pregnancy & lactation. Patients <18 yr.
Click to view SKIIP detailed prescribing information
Use In Pregnancy & Lactation
Click to view SKIIP detailed prescribing information
Adverse Reactions
Nausea; dryness of the mouth; cough; insomnia; vomiting; dizziness & headache; difficulty in swallowing; constipation; increased saliva production; hiccups; flatulence; indigestion/heartburn; diarrhea; stomach discomfort; being sick; sore or swollen throat; slightly sore or irritated mouth or tongue; shortness of breath; fast or irregular heartbeat; severe allergic reaction symptoms including sudden wheeziness or tightness of chest, rash & feeling faint.
Click to view SKIIP detailed prescribing information
Storage
View SKIIP storage conditions for details to ensure optimal shelf-life.
Description
View SKIIP description for details of the chemical structure and excipients (inactive components).
MIMS Class
Drugs Used in Substance Dependence
ATC Classification
N07BA01 - nicotine ; Belongs to the class of drugs used in the management of nicotine dependence.
Regulatory Classification
Non-Rx
Presentation/Packing
Form
SKIIP loz 2 mg
Packing/Price
((cherry flavor)) 10's; ((mint flavor)) 10's
Form
SKIIP loz 4 mg
Packing/Price
((cherry flavor)) 10's